Prevention and Surveillance

Asthma in the Workplace and Related Conditions: Third Edition

Volumn , Issue , 2006, Pages 353-376

  Liss, Gary M ^a   Nordman, Henrik ^b   Tarlo, Susan M ^a   Bernstein, David I ^c  

^a UNIVERSITY OF TORONTO   (Canada)

^b FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957332132     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.3109/9780849374531-18     Document Type: Chapter

References (124)

1. 1. Blanc PD, Toren K. How much adult asthma can be attributed to occupational factors? Am J Med 1999; 107(6):580-587.
2. American Thoracic Society Statement. Occupational contribution to the burden of airway disease. Am J Respir Crit Cre Med 2003; 167:787-797.
3. 3. Brooks SM, Weiss MA, Bernstein IL. Reactive airways dysfunction syndrome (RADS). Persistent asthma syndrome after high level irritant exposures. Chest 1985; 88(3): 376-384.
4. 4. Tarlo SM, Broder I. Irritant-induced occupational asthma. Chest 1989; 96(2):297-300.
5. 5. Bardana EJ Jr. Reactive airways dysfunction syndrome (RADS): guidelines for diagno-sis and treatment and insight into likely prognosis. Ann Allergy Asthma Immunol 1999; 83(6 Pt 2):583-586.
6. 6. Prezant DJ, Weiden M, Banauch GI, et al. Cough and bronchial responsiveness in fire-fighters at the World Trade Center site. N Engl J Med 2002; 347(11):806-815.
7. 7. Banauch GI, Alleyne D, Sanchez R, et al. Persistent hyperreactivity and reactive airway dysfunction in firefighters at the World Trade Center. Am J Respir Crit Care Med 2003; 168(1):54—62.
8. 8. Taylor AN. Role of human leukocyte antigen phenotype and exposure in development of occupational asthma. Curr Opin Allergy Clin Immunol 2001; 1(2):157-161.
9. 9. Niven RM, Pickering CA. Is atopy and smoking important in the workplace? Occup Med (Lond) 1999; 49(3):197-200.
10. 10. Gautrin D, Infante-Rivard C, Ghezzo H, Malo JL. Incidence and host determinants of probable occupational asthma in apprentices exposed to laboratory animals. Am J Respir Crit Care Med 2001; 163(4):899-904.
11. 11. Archambault S, Malo JL, Infante-Rivard C, Ghezzo H, Gautrin D. Incidence of sensi-tization, symptoms, and probable occupational rhinoconjunctivitis and asthma in apprentices starting exposure to latex. J Allergy Clin Immunol 2001; 107(5):921-923.
12. 12. Venables KM, Upton JL, Hawkins ER, Tee RD, Longbottom JL, Newman Taylor AJ. Smoking, atopy, and laboratory animal allergy. Br J Ind Med 1988; 45(10):667-671.
13. 13. Barker RD, van Tongeren MJ, Harris JM, Gardiner K, Venables KM, Newman Taylor AJ. Risk factors for bronchial hyperresponsiveness in workers exposed to acid anhydrides. Eur Respir J 2000; 15(4):710-715.
14. 14. Cullinan P, Tarlo S, Nemery B. The prevention of occupational asthma. Eur Respir J 2003; 22(5):853-860.
15. 15. Baur X, Huber H, Degens PO, Allmers H, Ammon J. Relation between occupational asthma case history, bronchial methacholine challenge, and specific challenge test in patients with suspected occupational asthma. Am J Ind Med 1998; 33(2):114—122.
16. 16. Bush RK, Stave GM. Laboratory animal allergy: an update. ILAR J 2003; 44(1):28-51.
17. 17. Tarlo SM, Liss GM, Dias C, Banks DE. Assessment of the relationship between isocya-nate exposure levels and occupational asthma. Am J Ind Med 1997; 32(5):517-521.
18. 18. Chan-Yeung M, Desjardins A. Bronchial hyperresponsiveness and level of exposure in occupational asthma due to western red cedar (Thujaplicata). Serial observations before and after development of symptoms. Am Rev Respir Dis 1992; 146(6):1606-1609.
19. 19. Charous BL, Blanco C, Tarlo S, et al. Natural rubber latex allergy after 12 years: recom-mendations and perspectives. J Allergy Clin Immunol 2002; 109(1):31-34.
20. 20. Bernstein DI, Karnani R, Biagini RE, et al. Clinical and occupational outcomes in health care workers with natural rubber latex allergy. Ann Allergy Asthma Immunol 2003; 90(2):209-213.
21. 21. Saary MJ, Kanani A, Alghadeer H, Holness DL, Tarlo SM. Changes in rates of natural rubber latex sensitivity among dental school students and staff members after changes in latex gloves. J Allergy Clin Immunol 2002; 109(1):131-135.
22. 22. Tarlo SM, Easty A, Eubanks K, et al. Outcomes of a natural rubber latex control program in an Ontario teaching hospital. J Allergy Clin Immunol 2001; 108(4):628-633.
23. 23. Liss GM, Tarlo SM. Natural rubber latex-related occupational asthma: association with interventions and glove changes over time. Am J Ind Med 2001; 40(4):347-353.
24. 24. Allmers H, Schmengler J, Skudlik C. Primary prevention of natural rubber latex allergy in the German health care system through education and intervention. J Allergy Clin Immunol 2002; 110(2):318-323.
25. 25. Tarlo SM, Wong L, Roos J, Booth N. Occupational asthma caused by latex in a surgi-cal glove manufacturing plant. J Allergy Clin Immunol 1990; 85(3):626-631.
26. 26. Orfan NA, Reed R, Dykewicz MS, Ganz M, Kolski GB. Occupational asthma in a latex doll manufacturing plant. J Allergy Clin Immunol 1994; 94(5):826-830.
27. 27. Valentino M, Pizzichini MA, Monaco F, Governa M. Latex-induced asthma in four healthcare workers in a regional hospital. Occup Med (Lond) 1994; 44(3):161-164.
28. 28. Vandenplas O. Occupational asthma caused by natural rubber latex. Eur Respir J 1995; 8(11):1957-1965.
29. 29. Ho A, Chan H, Tse KS, Chan-Yeung M. Occupational asthma due to latex in health care workers. Thorax 1996; 51(12):1280-1282.
30. 30. Tarlo SM, Sussman GL, Holness DL. Latex sensitivity in dental students and staff: a cross-sectional study. J Allergy Clin Immunol 1997; 99(3):396-401.
31. 31. Liss GM, Sussman GL, Deal K, et al. Latex allergy: epidemiologic study of 1,351 hospital workers. Occup Environ Med 1997; 54:335-342.
32. Sarlo K. Control of occupational asthma and allergy in the detergent industry. Ann Allergy Asthma Immunol 2003; 90(5 suppl 2):32-34.
33. 33. Schweigert MK, Mackenzie DP, Sarlo K. Occupational asthma and allergy associated with the use of enzymes in the detergent industry—a review of the epidemiology, toxicology and methods of prevention. Clin Exp Allergy 2000; 30(11):1511-1518.
34. 34. Cullinan P, Harris JM, Newman Taylor AJ, Hole AM, Jones M, Barnes F, Jolliffe G. An outbreak of asthma in a modern detergent factory. Lancet 2000; 356(9245):1899-1900.
35. 35. Tarlo SM, Liss GM, Yeung KS. Changes in rates and severity of compensation claims for asthma due to diisocyanates: a possible effect of medical surveillance measures. Occup Environ Med 2002; 59(1):58-62.
36. 36. Moussavi A, Dearman RJ, Kimber I, Kemeny DM. Cytokine production by CD4+ and CD8+ T cells in mice following primary exposure to chemical allergens: evidence for functional differentiation of T lymphocytes in vivo. Int Arch Allergy Immunol 1998; 116(2):116-123.
37. 37. Dearman RJ, Kimber I. Cytokine fingerprinting and hazard assessment of chemical respiratory allergy. J Appl Toxicol 2001; 21(2):153-163.
38. 38. Baur X. Are we closer to developing threshold limit values for allergens in the workplace? Ann Allergy Asthma Immunol 2003; 90(5 suppl 2):11-18.
39. 39. Balmes JR. Surveillance for occupational asthma. Occup Med: State Art Rev 1991; 6:101-110.
40. 40. Fabbri LM, Danieli D, Crescioli S, et al. Fatal asthma in a subject sensitized to toluene diisocyanate. Am Rev Respir Dis 1988; 137:1494-1498.
41. 41. Carino M, Aliani M, Licitra C, Sarno N, Ioli F. Death due to asthma at workplace in a diphenylmethane diisocyanate-sensitized subject. Respiration 1997; 64:111-113.
42. 42. Erlich I. Fatal asthma in a baker: a case report. Am J Ind Med 1994; 26:799.
43. Brooks SM. Occupational asthma. Toxicol Lett 1995; 82/83:39-45.
44. 44. National Institute for Occupational Safety and Health. Criteria for a Recommended Standard: Occupational Exposure to Diisocyanates. Cincinnati, Ohio: National Insti-tute for Occupational Safety and Health, 1978 (DHEW Publication no. 78-215).
45. 45. National Institute for Occupational Safety and Health. Preventing Asthma and Death from Diisocyanate Exposure. Cincinnati, Ohio: National Institute for Occupational Safety and Health, 1996 [DHHS (NIOSH) Publication No. 96-111].
46. Ontario Ministry of Labour. Regulation respecting isocyanates made under the Occupational Health and Safety Act, 1980. Revised Statutes of Ontario, 1983; chapter 321, Ontario Regulation 455,80.
47. COSHH. Control of Substances Hazardous to Health Regulations 1988. SI 1657. London: HMO, 1988.
48. 48. Chan-Yeung M, Brooks S, Alberts M, et al. ACCP Consensus Statement: assessment of asthma in the workplace. Chest 1995; 108:1084-1117.
49. 49. Tarlo SM, Banks D, Liss G, Broder I. Outcome determinants for isocyanate induced occupational asthma among compensation claimants. Occup Environ Med 1997; 54(10):756-761.
50. 50. Lozewicz S, Assoufi BK, Hawkins R, Taylor AJ. Outcome of asthma induced by isocyanates. Br J Dis Chest 1987; 81(1):14-22.
51. 51. Gannon PF, Weir DC, Robertson AS, Burge PS. Health, employment, and financial outcomes in workers with occupational asthma. Br J Ind Med 1993; 50(6):491-496.
52. 52. Conner PR. Experience with early detection of toluene diisocyanate-associated occupa-tional asthma. Appl Occup Environ Hyg 2002; 17(12):856-862.
53. 53. Nicholson PJ, Newman Taylor AJ, Oliver P, Cathcart M. Current best practice for the health surveillance of enzyme workers in the soap and detergent industry. Occup Med (Lond) 2001; 51(2):81-92.
54. 54. Merget R, Caspari C, Dierkes-Globisch A, et al. Effectiveness of a medical surveillance program for the prevention of occupational asthma caused by platinum salts: a nested case-control study. J Allergy Clin Immunol 2001; 107(4):707-712.
55. 55. Tee RD, Cullinan P, Welch J, Burge PS, Newman-Taylor AJ. Specific IgE to isocya-nates: a useful diagnostic role in occupational asthma. J Allergy Clin Immunol 1998; 101(5):709-715.
56. 56. Liss GM, Tarlo SM, Macfarlane Y, Yeung KS. Hospitalization among workers com-pensated for occupational asthma. Am J Respir Crit Care Med 2000; 162(1):112-118.
57. 57. Baur X, Stahlkopf J, Merget R. Prevention of occupational asthma including medical surveillance. Am J Ind Med 1998; 34:632-639.
58. 58. Poonai N, van Diepen S, Bharatha A, Manduch M, Deklay T, Tarlo SM. Barriers to diagnosis of occupational asthma in Ontario. Can J Public Health 2005; 96: 230-233.
59. 59. Kraw M, Tarlo SM. Isocyanate medical surveillance: respiratory referrals from a foam manufacturing plant over a five-year period. Am J Ind Med 1999; 35(1):87-91.
60. 60. Bernstein DI, Korbee L, Stauder T, Bernstein JA, Bernstein IL. The low prevalence of occupational asthma and antibody dependent sensitization to diphenylmethane diiso-cyanate (MDI) in a plant engineered for minimal exposure to diisocyanates. J Allergy Clin Immunol 1993; 92:387-396.
61. 61. Gordon SB, Curran AD, Murphy J, et al. Screening questionnaires for bakers’ asthma—are they worth the effort? Occup Med (Lond) 1997; 47(6):361-366.
62. 62. Malo J-L, Ghezzo H, L’Archeveque J, Lagier F, Perrin B, Cartier A. Is the clinical history a satisfactory means for diagnosing occupational asthma? Am Rev Respir Dis 1991; 143:528-532.
63. 63. Meijer E, Grobbee DE, Heederik D. A strategy for health surveillance in laboratory ani-mal workers exposed to high molecular weight allergens. Occup Environ Med 2004; 61:831-837.
64. 64. Bernstein DI, Bernstein IL, Gaines WG, Stauder T, Wilson ER. Characterization of skin prick testing responses for detecting sensitization to detergent enzymes at extreme dilutions. Inability of the RAST to detect lightly sensitized individuals. J Allergy Clin Immunol 1994; 94:498-507.
65. 65. Merget R, Stollfuss J, Wiewrodt R, et al. Diagnostic tests in enzyme allergy. J Allergy Clin Immunol 1993; 92:264-277.
66. Newman Taylor AJ, Nicholson PJ, Cullinan P, Boyle C, Burge PS. Guidelines for the Prevention, Identification & Management of Occupational Asthma: Evidence Review & Recommendations. British Occupational Health Research Foundation, London, www.bohrf.org.uk/downloads/asthevre.pdf, 2004.
67. 67. Malo J-L, Ghezzo H, D’Aquino C, L’Archeveque J, Cartier A, Chan-Yeung M. Natural history of occupational asthma: relevance of type of agent and other factors on the rate of development of symptoms in subjects with disease. J Allergy Clin Immu-nol 1992; 90:937-943.
68. Chan-Yeung M, Malo J-L. Natural history of occupational asthma. In: Bernstein IL, Chan-Yeung M, Malo J-L, Bernstein DI, eds. Asthma in the Workplace. 2d ed. New York: Marcel Dekker Inc., 1993:129-143 (Chapter 7).
69. 69. Lemiere C, Malo JL, Boulet LP, Boutet M. Reactive airways dysfunction syndrome induced by exposure to a mixture containing isocyanate: functional and histopathologic behaviour. Allergy 1996; 51(4):262-265.
70. 70. Tarlo SM, Boulet LP, Cartier A, et al. Canadian Thoracic Society guidelines for occu-pational asthma. Can Respir J 1998; 5(4):289-300.
71. 71. Tarlo SM, Liss GM. Occupational asthma: an approach to diagnosis and management. CMAJ 2003; 168(7):867-871.
72. 72. Vandenplas O, Jamart J, Delwiche JP, Evrard G, Larbanois A. Occupational asthma caused by natural rubber latex: outcome according to cessation or reduction of expo-sure. J Allergy Clin Immunol 2002; 109(1):125-130.
73. 73. Allmers H, Brehler R, Chen Z, Raulf-Heimsoth M, Fels H, Baur X. Reduction of latex allergens and latex-specific IgE antibodies in sensitized workers after removal of powdered natural rubber latex gloves in a hospital. J Allergy Clin Immunol 1998; 102(5):841-846.
74. 74. Baur X, Chen Z, Allmers H. Can a threshold limit value for natural rubber latex airborne allergens be defined? J Allergy Clin Immunol 1998; 101(1 Part 1):24-27.
75. 75. Slovak AJ, Orr RG, Teasdale EL. Efficacy of the helmet respirator in occupational asthma due to laboratory animal allergy (LAA). Am Ind Hyg Assoc J 1985; 46(8):411-415.
76. 76. Taivainen AI, Tukiainen HO, Terho EO, Husman KR. Powered dust respirator helmets in the prevention of occupational asthma among farmers. Scand J Work Environ Health 1998; 24(6):503-507.
77. 77. Cistero Bahima A, Sastre J, Enrique E, et al. Tolerance and effects on skin reactivity to latex of sublingual rush immunotherapy with a latex extract. J Invest Allergol Clin Immunol 2004; 14(1):17-25.
78. 78. Tarlo SM, Sussman G, Contala A, Swanson BA. Control of airborne latex by use of powder-free latex gloves. J Allergy Clin Immunol 1994; 93(6):985-989.
79. 79. Meredith S, Blanc P. Surveillance: clinical and epidemiological perspectives. In: Hendrick DJ, Burge PS, Beckett WS, Churg A, eds. Occupational Disorders of the Lung. W.B. Saunders, 2002:7-23.
80. 80. Baker EL. Sentinel Event Notification System for Occupational Risks (SENSOR): the concept. Am J Public Health 1989; 79(suppl):18-20.
81. 81. Matte T, Hoffman R, Rosenman K, Stanbury M. Surveillance of occupational asthma under the SENSOR model. Chest 1990; 98:173S-178S.
82. 82. Rosenman KD, Reilly MJ, Kalinowski DJ. A state-based surveillance system for work-related asthma. J Occup Environ Med 1997; 39(5):415-425.
83. 83. Henneberger PK, Kreiss K, Rosenman K, Reilly MJ, Chang YF, Geidenberger C. An evaluation of the incidence of work-related asthma in the United States. Int J Occup Environ Health 1999; 5:1-8.
84. 84. Reilly MJ, Rosenman KD, Watt FC, et al. Surveillance for occupational asthma— Michigan and New Jersey, 1988-1992. MMWR CDC Surveill Summ 1994; 43(1):9-17.
85. 85. Reinisch F, Harrison RJ, Cussler S, et al. Physician reports of work-related asthma in California 1993-1996. Am J Ind Med 2001; 39:72-83.
86. 86. DiStefano F, Siriruttanapruk S, McCoach J, Burge PS. The incidence of occupational asthma in the West Midlands (UK) from the Shield surveillance scheme. Eur Respir J 1998; 12(suppl 28):30S.
87. 87. Meredith S. Reported incidence of occupational asthma in the United Kingdom, 1989-1990. J Epidemiol Community Health 1993; 47:459-463.
88. 88. Gannon PFG, Burge PS. A preliminary repot of a surveillance scheme of occupational asthma in the West Midlands. Br J Ind Med 1991; 48:579-582.
89. 89. McDonald JC, Keynes HL, Meredith SK. Reported incidence of occupational asthma in the United Kingdom, 1989-1997. Occup Environ Med 2000; 57:823-829.
90. 90. Meyer JD, Holt DL, Chen Y, Cherry NM, McDonald JC. SWORD ‘‘99’’: surveillance of work-related and occupational respiratory disease in the UK. Occup Med 2001; 51:204-208.
91. 91. Hnizdo E, Esterhuizen TM, Rees D, Lalloo UG. Occupational asthma as identified by the Surveillance of Work-related and occupational respiratory diseases programme in South Africa. Clin Exp Allergy 2001; 31:32-39.
92. 92. Contreras GR, Rousseau R, Chan-Yeng M. Occupational diseases in British Columbia, Canada in 1991. Occup Environ Med 1994; 51:710-712.
93. 93. Provencher S, Labreche FB, Deguire L. Physician based surveillance system for occupational respiratory diseases—the experience of PROPULSE, Quebec, Canada. Occup Environ Med 1997; 54:272-276.
94. 94. Karjalainen A, Kurppa K, Virtanen S, Keskinen H, Nordman H. Incidence of occupa-tional asthma by occupation and industry in Finland. Am J Ind Med 2000; 37:451-458.
95. Toren K. Self-reported rate of occupational asthma in Sweden 1990-1992. Occup Environ Med 1996; 53(11):757-761.
96. 96. Goldman L. RIDDOR revisited. Occup Health (Lond) 1996; 48(4):139-140.
97. 97. Brooks A, Ward FG. Assessment of disability under the Social Security Industrial Injuries Benefit Scheme. Occup Med (Lond) 1997; 47(2):112-116.
98. 98. Xu X, Christiani DC. Occupational exposures and physician diagnosed asthma. Chest 1993; 194:1364-1370.
99. 99. Milton DK, Solomon GM, Rosiello RA, Herrick RP. Risk and incidence of asthma attributable to occupational exposure among HMO members. Am J Ind Med 1998; 33:1-10.
100. Karjalainen A, Kurppa K, Martikainen R, Klaukka T, Karjalainen J. Work is related to a substantial portion of adult-onset asthma incidence in the Finnish population. Am J Respir Crit Care Med 2001; 164:565-568.
101. Reijula K, Haahtela T, Klaukka T, Rantanen J. Incidence of occupational asthma and persistent asthma in young adults has increased in Finland. Chest 1996; 110(1):58-61.
102. Karjalainen A, Kurppa K, Martikainen R, Karjalainen J, Klaukka T. Exploration of asthma risk by occupation—extended analysis of an incidence study of the Finnish population. Scand J Work Environ Health 2002; 28:49-57.
103. Wagner GR, Wegman DH. Occupational asthma: prevention by definition. Am J Ind Med 1998; 33:427-429.
104. Kogevinas M, Anto JM, Sunyer J, Kromhout H, Burney P. Occupational asthma in Europe and other industrialized areas: a population-based study. European Community Respiratory Health Survey Study Group. Lancet 1999; 22(353):1750-1754.
105. Flodin U, Ziegler J, Jonsson P, Axelson O. Bronchial asthma and air pollution at work-places. Scand J Work Environ Health 1996; 22:451-456.
106. Ng TP, Hong CY, Wong ML, Koh KT, Ling SL. Risks of asthma associated with occu-pations in a community-based case-control study. Am J Ind Med 1994; 25:709-718.
107. Karjalainen A, Martikainen R, Karjalianen J, Klaukka T, Kurppa K. Excess incidence of asthma among Finnish cleaners employed in different industries. Eur Respir J 2002; 19:90-95.
108. Zock JP, Kogevinas M, Sunyer J, Jarvis D, Toren K, Anto JM. Asthma characteristics in cleaning workers, workers in other risk jobs and office workers. Eur Respir J 2002; 20:679-685.
109. Arif AA, Whitehead LW, Delclos GL, Lee ES. Prevalence and risk factors of work related asthma by industry among United States workers: data from the third national health and nutrition examination survey (1988-1994). Occup Environ Med 2002; 59:505-511.
110. Liss GM, Tarlo SM. Occup Environ Med 2002; 59(8):503-504.
111. Jaakkola M, Nordman H, Piipari R, et al. Indoor dampness and molds and develop-ment of adult-onset asthma: a population-based incident case-control study. Environ Health Perspect 2001; 110(5):543-547.
112. Thorn J, Brisman J, Toren K. Adult-onset asthma is associated with self-reported mould or environmental tobacco smoke exposures in the home. Allergy 2001; 56: 287-292.
113. Flindt M. Pulmonary disease due to inhalation of derivatives of Bacillus subtilis contain-ing proteolytic enzyme. Lancet 1969; 1:1177-1181.
114. Juniper C, How M, Goodwin B. Bacillus subtilis enzymes: a 7-year clinical, epidemio-logical and immunological study of an industrial allergen. J Soc Occup Med 1977; 27: 3-12.
115. Jarvinen KAJ, Pirila V, Bjorksten F, Keskinen H, Lehtinen M, Stubb. Unsuitability of bakery work for a person with atopy: a study on 234 bakery workers. Ann Allergy 1979; 42:192-195.
116. Nordman H. Occupational asthma—time for prevention. Scand J Work Environ Health 1994; 20(special issue):108-115.
117. Cockroft A, Edwards J, McCarthy P. The role of pre-employment allergy screening in animal work. Eur J Respir Dis 1981; 62(suppl 11):42-43.
118. Lutsky I, Ksalbfleish JH, Fink JN. Occupational allergy to laboratory animals: employer practices. J Occup Med 1983; 25:372-376.
119. Botham P, Davies G, Teasdale E. Allergy to laboratory animals: a prospective study of its incidence and of the influence of atopy on its development. Br J Ind Med 1987; 44:627-632.
120. Gautrin D, Ghezzo H, Infante-Rivard C, Malo JL. Natural history of sensitization, symptoms and diseases in apprentices exposed to laboratory animals. Eur Respir J 2001; 17:904-908.
121. Gautrin D, Ghezzo H, Infante-Rivard C, Malo JL. Host determinants for the develop-ment of allergy in apprentices exposed to laboratory animals. Eur Respir J 2002; 19: 96-103.
122. Cullinan P, Lowson D, Nieuwenhuijsen MJ, et al. Work related symptoms, sensitiza-tion, and estimated exposure in workers not previously exposed to flour. Occup Environ Med 1994; 51:579-583.
123. Houba R, Heederik D, Doekes G. Wheat sensitisation and work related symptoms in the baking industry are preventable: an epidemiological study. Am J Respir Crit Care Med 1998; 158:1499-1503.
124. Houba R, Heederik DJJ, Doekes G, van Run PEM. Exposure-sensitization relationship for a-amylase allergens in the baking industry. Am J Respir Crit Care Med 1996; 154:130-136.